CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)
Close on Nov 18, 2026Market cap $350.75MP/E –Yield –
CorMedix net income
Net income is the profit left for shareholders after every expense, interest and tax.
CorMedix's net income for the twelve months ending Jun 30, 2026 was $187.17M, up 265.9% year over year. For fiscal 2025 it was $163.06M. The highest annual figure on record is $163.06M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $163.06M | – |
| FY2024 | Dec 31, 2024 | -$17.93M | – |
| FY2023 | Dec 31, 2023 | -$46.34M | – |
| FY2022 | Dec 31, 2022 | -$29.70M | – |
| FY2021 | Dec 31, 2021 | -$28.21M | – |
| FY2020 | Dec 31, 2020 | -$22.03M | – |
| FY2019 | Dec 31, 2019 | -$16.43M | – |
| FY2018 | Dec 31, 2018 | -$26.83M | – |
| FY2017 | Dec 31, 2017 | -$33.01M | – |
| FY2016 | Dec 31, 2016 | -$24.64M | – |
| FY2015 | Dec 31, 2015 | -$18.19M | – |
| FY2014 | Dec 31, 2014 | -$20.45M | – |
| FY2013 | Dec 31, 2013 | -$9.13M | – |
| FY2012 | Dec 31, 2012 | -$3.38M | – |
| FY2011 | Dec 31, 2011 | -$6.67M | – |
| FY2010 | Dec 31, 2010 | -$10.91M | – |
| FY2009 | Dec 31, 2009 | -$8.12M | – |
| FY2008 | Dec 31, 2008 | -$9.00M | – |
| FY2007 | Dec 31, 2007 | -$7.24M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $25.99M | +31.1% |
| Q1 FY2026 | Mar 31, 2026 | $38.60M | +87.0% |
| Q4 FY2025 | Dec 31, 2025 | $14.02M | +4.1% |
| Q3 FY2025 | Sep 30, 2025 | $108.56M | – |
| Q2 FY2025 | Jun 30, 2025 | $19.83M | – |
| Q1 FY2025 | Mar 31, 2025 | $20.64M | – |
| Q4 FY2024 | Dec 31, 2024 | $13.46M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.78M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.75M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.57M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.21M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.60M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.79M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.57M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.63M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.09M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.60M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.78M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.56M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.30M | -346.9% |
| Q3 FY2019 | Sep 30, 2019 | -$5.26M | – |
| Q2 FY2019 | Jun 30, 2019 | -$696.16K | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.17M | – |
| Q4 FY2018 | Dec 31, 2018 | $2.15M | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.24M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.56M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.19M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.31M | – |
| Q3 FY2017 | Sep 30, 2017 | -$9.96M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.15M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.60M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.40K | – |
| Q3 FY2016 | Sep 30, 2016 | -$9.13M | – |
See a number that looks wrong?